• Skip to primary navigation
  • Skip to main content
  • Skip to primary navigation
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
College of Medicine
  • UAMS Health
  • Jobs
  • Giving
  • About Us
    • Fast Facts
    • Leadership
    • Features
    • COMmunication Newsletter
    • Maps and Directions
    • College of Medicine History
    • Professionalism Guidelines
  • Departments
  • Admissions
    • New Admissions Standards 2026
    • Applicant Guide and Timeline
    • One Medical School, Two Campuses
    • Freshman Scholarships
    • AMCAS Choose Your Medical School Tool Dates
    • Core Competencies for Entering Medical Students
    • Three-Year M.D. Program
    • M.D./MPH Program
    • M.D./Ph.D. Program
    • M.D./MBA Program
    • Rural Practice Programs
      • Community Match Rural Physician Recruitment Program
      • Rural Practice Scholarship Program
      • Rural Recruitment and Job Opportunities
    • Postbaccalaureate Pre-Med Program
    • Transfer Students Policy
  • Students
    • Academic Calendar
    • Academic Houses
    • Career Advising
    • Financial Aid and Scholarships
    • Visiting Students
    • Mentor Spotlight Podcast
    • Preparing for Residency
    • Non-Discrimination Statement
    • Outstanding Teacher Nominations
    • Parents Club
    • Student Links
    • Honors in Research
    • UAMS Campus Security
    • Undergraduate Medical Education Competencies
  • Graduate Medical Education
  • Alumni
  • Faculty Affairs
  • Research
  1. University of Arkansas for Medical Sciences
  2. College of Medicine
  3. Clinical Trial Promising for Ovarian Cancer Treatment

Clinical Trial Promising for Ovarian Cancer Treatment

Eighteen years ago, Gail Clayton received news that changed her life. Looking back, she says finding out she had breast cancer marked the beginning of new perspectives.

“When I was first diagnosed with cancer, it wasn’t the end of life as so many people think. To me, it was the beginning of life.”

Clayton and her husband, Raymond, have been married 46 years. He calls UAMS one of Arkansas’ best kept secrets.

“I don’t think people realize how amazing this institution is,” Clayton said. “You become friends with your doctors and nurses. It takes a village and I believe that village is right within these walls at UAMS.

Kristin Zorn, M.D.
Kristin Zorn, M.D., is a gynecologic oncologist at UAMS.

She had breast cancer twice and was recently diagnosed with ovarian cancer. That prompted Clayton’s oncologist, Laura Hutchins, M.D., to refer her to gynecologic oncologist Kristin Zorn, M.D., associate professor and division director in the College of Medicine Department of Obstetrics and Gynecology.

“Anytime we see a patient with a new diagnosis of cancer in the ovaries, fallopian tubes or the peritoneum (the internal lining of the abdomen), we think of a possible hereditary source for that cancer,” Zorn said.

Clayton and Zorn discussed genetic counseling and ultimately found Clayton had a mutation in one of the BRCA genes, commonly known as the breast cancer genes. Every person is born with the BRCA1 and BRCA2 genes, but women who inherit mutations of the genes have an increased chance of developing breast, ovarian, and other cancers.

Researchers’ knowledge about these genetic mutations has helped lead to development of a new class of drugs known as PARP inhibitors.

Zorn and Clayton discuss
Zorn and Clayton discuss Clayton’s participation in the clinical trial.

“PARP inhibitors capitalize on the genetic defect that’s already present in people who carry one of these mutations,” Zorn said. “It helps to kill the cancer cells that are accumulating DNA damage.”

There are three types of PARP inhibitors that have been FDA-approved over the past few years: olaparib, rucaparib and niraparib. Clayton is a part of a clinical trial that includes her taking olaparib.

“With PARP inhibitors, we first focused on people who carry a BRCA or similar mutation. We’re now finding many patients with ovarian cancer who do not have a mutation are responding to the drugs.”

Another advantage of this new class of drugs is that they can be taken orally rather than through intravenous infusion, making it more convenient for patients. This works especially well for Clayton who spends a great deal of her time seeing the world.

Raymond and Gail Clayton
Raymond and Gail Clayton

“If someone says go, we pack a bag and go.”

Since her first diagnosis, Clayton says she takes nothing for granted and began living in a way she may not have if not for the illness. She and Raymond Clayton have made lots of memories abroad. Sometimes their adult son Randy joins them.

“We’ve been to the Baltic States, Russia, Berlin, Sweden…”

She’s responded well to the clinical trial and shows no indications of slowing down.

“…England, Paris, the Caribbean, Ireland. It’s been a journey.”

“Part of the reason I’m so passionate about practicing at a place like UAMS, is that it helps us bring cutting-edge therapies to our patients,” Zorn said. “Sometimes we’re talking about a surgical advance, sometimes we’re talking about an advance in treatment.”

Zorn says genetic counseling and testing has become a standard of care in some of the most common gynecological cancers.

“While many parts of the country are having trouble keeping up with the change in the standard of care, UAMS has a genetic counselor embedded in our clinic so that we can accomplish that.”

“The way I see it,” said Clayton, “Even if the clinical trial didn’t work for me, maybe it would work for someone else. I’m grateful for the strides scientists have made in treating this disease.”

This clinical trial was developed through the NRG Oncology cooperative trial group of the National Cancer Institute. The only access to this trial in Arkansas is at UAMS.

By Katrina Dupins| January 18th, 2018

Posted by Chris Lesher on January 18, 2018

Filed Under: News

UAMS College of Medicine LogoUAMS College of MedicineUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 296-1100
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2025 University of Arkansas for Medical Sciences